FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4211228787> ?p ?o ?g. }

• W4211228787 abstract "Acute respiratory distress syndrome (ARDS) is triggered by various aetiological factors such as trauma, sepsis and respiratory viruses including SARS-CoV-2 and influenza A virus. Immune profiling of severe COVID-19 patients has identified a complex pattern of cytokines including granulocyte macrophage-colony stimulating factor (GM-CSF) and interleukin (IL)-5, which are significant mediators of viral-induced hyperinflammation. This strong response has prompted the development of therapies that block GM-CSF and other cytokines individually to limit inflammation related pathology. The common cytokine binding site of the human common beta (βc) receptor signals for three inflammatory cytokines: GM-CSF, IL-5 and IL-3. In this study, βc was targeted with the monoclonal antibody (mAb) CSL311 in engineered mice devoid of mouse βc and βIL-3 and expressing human βc (hβcTg mice). Direct pulmonary administration of lipopolysaccharide (LPS) caused ARDS-like lung injury, and CSL311 markedly reduced lung inflammation and oedema, resulting in improved oxygen saturation levels in hβcTg mice. In a separate model, influenza (HKx31) lung infection caused viral pneumonia associated with a large influx of myeloid cells into the lungs of hβcTg mice. The therapeutic application of CSL311 potently decreased accumulation of monocytes/macrophages, neutrophils, and eosinophils without altering lung viral loads. Furthermore, CSL311 treatment did not limit the viral-induced expansion of NK and NKT cells, or the tissue expression of type I/II/III interferons needed for efficient viral clearance. Simultaneously blocking GM-CSF, IL-5 and IL-3 signalling with CSL311 may represent an improved and clinically applicable strategy to reducing hyperinflammation in the ARDS setting." @default.
• W4211228787 created "2022-02-13" @default.
• W4211228787 creator A5014102803 @default.
• W4211228787 creator A5016879803 @default.
• W4211228787 creator A5032340430 @default.
• W4211228787 creator A5033823934 @default.
• W4211228787 creator A5048621308 @default.
• W4211228787 creator A5049372181 @default.
• W4211228787 creator A5058540596 @default.
• W4211228787 creator A5060211723 @default.
• W4211228787 creator A5066882766 @default.
• W4211228787 creator A5079475266 @default.
• W4211228787 date "2022-02-10" @default.
• W4211228787 modified "2023-10-09" @default.
• W4211228787 title "Blocking the human common beta subunit of the GM-CSF, IL-5 and IL-3 receptors markedly reduces hyperinflammation in ARDS models" @default.
• W4211228787 cites W132890375 @default.
• W4211228787 cites W1971232830 @default.
• W4211228787 cites W1977447968 @default.
• W4211228787 cites W1986710274 @default.
• W4211228787 cites W2011987715 @default.
• W4211228787 cites W2032726021 @default.
• W4211228787 cites W2038871743 @default.
• W4211228787 cites W2042383304 @default.
• W4211228787 cites W2068466537 @default.
• W4211228787 cites W2092879755 @default.
• W4211228787 cites W2100213157 @default.
• W4211228787 cites W2115249251 @default.
• W4211228787 cites W2120194361 @default.
• W4211228787 cites W2184655932 @default.
• W4211228787 cites W2200423187 @default.
• W4211228787 cites W2280467808 @default.
• W4211228787 cites W2419382087 @default.
• W4211228787 cites W2610387541 @default.
• W4211228787 cites W2611509799 @default.
• W4211228787 cites W2766351289 @default.
• W4211228787 cites W2895842688 @default.
• W4211228787 cites W2898980899 @default.
• W4211228787 cites W2900736903 @default.
• W4211228787 cites W2917956764 @default.
• W4211228787 cites W2967633944 @default.
• W4211228787 cites W2972657499 @default.
• W4211228787 cites W3006394520 @default.
• W4211228787 cites W3011230498 @default.
• W4211228787 cites W3024541652 @default.
• W4211228787 cites W3035293132 @default.
• W4211228787 cites W3041582510 @default.
• W4211228787 cites W3043831218 @default.
• W4211228787 cites W3048259608 @default.
• W4211228787 cites W3080378920 @default.
• W4211228787 cites W3081752913 @default.
• W4211228787 cites W3085804104 @default.
• W4211228787 cites W3085958090 @default.
• W4211228787 cites W3086298873 @default.
• W4211228787 cites W3094282922 @default.
• W4211228787 cites W3094827753 @default.
• W4211228787 cites W3121015396 @default.
• W4211228787 cites W3129719580 @default.
• W4211228787 cites W3132811058 @default.
• W4211228787 cites W3133049945 @default.
• W4211228787 cites W3134718368 @default.
• W4211228787 cites W3135413123 @default.
• W4211228787 cites W3167630409 @default.
• W4211228787 cites W4253987686 @default.
• W4211228787 cites W859299 @default.
• W4211228787 doi "https://doi.org/10.1038/s41419-022-04589-z" @default.
• W4211228787 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35145069" @default.
• W4211228787 hasPublicationYear "2022" @default.
• W4211228787 type Work @default.
• W4211228787 citedByCount "7" @default.
• W4211228787 countsByYear W42112287872022 @default.
• W4211228787 countsByYear W42112287872023 @default.
• W4211228787 crossrefType "journal-article" @default.
• W4211228787 hasAuthorship W4211228787A5014102803 @default.
• W4211228787 hasAuthorship W4211228787A5016879803 @default.
• W4211228787 hasAuthorship W4211228787A5032340430 @default.
• W4211228787 hasAuthorship W4211228787A5033823934 @default.
• W4211228787 hasAuthorship W4211228787A5048621308 @default.
• W4211228787 hasAuthorship W4211228787A5049372181 @default.
• W4211228787 hasAuthorship W4211228787A5058540596 @default.
• W4211228787 hasAuthorship W4211228787A5060211723 @default.
• W4211228787 hasAuthorship W4211228787A5066882766 @default.
• W4211228787 hasAuthorship W4211228787A5079475266 @default.
• W4211228787 hasBestOaLocation W42112287871 @default.
• W4211228787 hasConcept C126322002 @default.
• W4211228787 hasConcept C142724271 @default.
• W4211228787 hasConcept C203014093 @default.
• W4211228787 hasConcept C2522874641 @default.
• W4211228787 hasConcept C2776348555 @default.
• W4211228787 hasConcept C2776914184 @default.
• W4211228787 hasConcept C2777546802 @default.
• W4211228787 hasConcept C2777714996 @default.
• W4211228787 hasConcept C2778158872 @default.
• W4211228787 hasConcept C2778690821 @default.
• W4211228787 hasConcept C2779134260 @default.
• W4211228787 hasConcept C3008058167 @default.
• W4211228787 hasConcept C524204448 @default.
• W4211228787 hasConcept C71924100 @default.
• W4211228787 hasConcept C86803240 @default.
• W4211228787 hasConcept C8891405 @default.
• W4211228787 hasConceptScore W4211228787C126322002 @default.

• next